These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 36329611)

  • 1. Rapid ex vivo reverse genetics identifies the essential determinants of prion protein toxicity.
    Reimann RR; Puzio M; Rosati A; Emmenegger M; Schneider BL; Valdés P; Huang D; Caflisch A; Aguzzi A
    Brain Pathol; 2023 Mar; 33(2):e13130. PubMed ID: 36329611
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conformational switch controlling the toxicity of the prion protein.
    Frontzek K; Bardelli M; Senatore A; Henzi A; Reimann RR; Bedir S; Marino M; Hussain R; Jurt S; Meisl G; Pedotti M; Mazzola F; Siligardi G; Zerbe O; Losa M; Knowles T; Lakkaraju A; Zhu C; Schwarz P; Hornemann S; Holt MG; Simonelli L; Varani L; Aguzzi A
    Nat Struct Mol Biol; 2022 Aug; 29(8):831-840. PubMed ID: 35948768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The toxicity of antiprion antibodies is mediated by the flexible tail of the prion protein.
    Sonati T; Reimann RR; Falsig J; Baral PK; O'Connor T; Hornemann S; Yaganoglu S; Li B; Herrmann US; Wieland B; Swayampakula M; Rahman MH; Das D; Kav N; Riek R; Liberski PP; James MN; Aguzzi A
    Nature; 2013 Sep; 501(7465):102-6. PubMed ID: 23903654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion infections and anti-PrP antibodies trigger converging neurotoxic pathways.
    Herrmann US; Sonati T; Falsig J; Reimann RR; Dametto P; O'Connor T; Li B; Lau A; Hornemann S; Sorce S; Wagner U; Sanoudou D; Aguzzi A
    PLoS Pathog; 2015 Feb; 11(2):e1004662. PubMed ID: 25710374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N-terminal domain of the prion protein is required and sufficient for liquid-liquid phase separation: A crucial role of the Aβ-binding domain.
    Kamps J; Lin YH; Oliva R; Bader V; Winter R; Winklhofer KF; Tatzelt J
    J Biol Chem; 2021 Jul; 297(1):100860. PubMed ID: 34102212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proposed mechanism for the promotion of prion conversion involving a strictly conserved tyrosine residue in the β2-α2 loop of PrPC.
    Kurt TD; Jiang L; Bett C; Eisenberg D; Sigurdson CJ
    J Biol Chem; 2014 Apr; 289(15):10660-10667. PubMed ID: 24596090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural effects of the highly protective V127 polymorphism on human prion protein.
    Hosszu LLP; Conners R; Sangar D; Batchelor M; Sawyer EB; Fisher S; Cliff MJ; Hounslow AM; McAuley K; Leo Brady R; Jackson GS; Bieschke J; Waltho JP; Collinge J
    Commun Biol; 2020 Jul; 3(1):402. PubMed ID: 32728168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion neurotoxicity: insights from prion protein mutants.
    Solomon IH; Schepker JA; Harris DA
    Curr Issues Mol Biol; 2010; 12(2):51-61. PubMed ID: 19767650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bispecific immunotweezer prevents soluble PrP oligomers and abolishes prion toxicity.
    Bardelli M; Frontzek K; Simonelli L; Hornemann S; Pedotti M; Mazzola F; Carta M; Eckhardt V; D'Antuono R; Virgilio T; González SF; Aguzzi A; Varani L
    PLoS Pathog; 2018 Oct; 14(10):e1007335. PubMed ID: 30273408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of antibody fragments for immunotherapy of prion diseases.
    Campana V; Zentilin L; Mirabile I; Kranjc A; Casanova P; Giacca M; Prusiner SB; Legname G; Zurzolo C
    Biochem J; 2009 Mar; 418(3):507-15. PubMed ID: 19000036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PrP knock-out and PrP transgenic mice in prion research.
    Weissmann C; Flechsig E
    Br Med Bull; 2003; 66():43-60. PubMed ID: 14522848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation-Dependent Refolding of Prion Protein Unveils Amyloidogenic-Related Structural Ramifications: Insights from Molecular Dynamics Simulations.
    Palaniappan C; Narayanan RC; Sekar K
    ACS Chem Neurosci; 2021 Aug; 12(15):2810-2819. PubMed ID: 34296847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in the histo-molecular pathology of human prion disease.
    Baiardi S; Rossi M; Capellari S; Parchi P
    Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of variant Creutzfeldt-Jakob disease prions in vivo by the Hsp70 disaggregase system.
    Thackray AM; Lam B; McNulty EE; Nalls AV; Mathiason CK; Magadi SS; Jackson WS; Andréoletti O; Marrero-Winkens C; Schätzl H; Bujdoso R
    Brain; 2022 Sep; 145(9):3236-3249. PubMed ID: 35446941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central residues in prion protein PrP
    Pasiana AD; Miyata H; Chida J; Hara H; Imamura M; Atarashi R; Sakaguchi S
    J Biol Chem; 2022 Sep; 298(9):102381. PubMed ID: 35973512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Channel Activities of the Full-Length Prion and Truncated Proteins.
    Wu J; Wang X; Lakkaraju A; Sternke-Hoffmann R; Qureshi BM; Aguzzi A; Luo J
    ACS Chem Neurosci; 2024 Jan; 15(1):98-107. PubMed ID: 38096481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Terminal Regions of Prion Protein: Functions and Roles in Prion Diseases.
    Hara H; Sakaguchi S
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A domain responsible for spontaneous conversion of bank vole prion protein.
    Kobayashi A; Matsuura Y; Takeuchi A; Yamada M; Miyoshi I; Mohri S; Kitamoto T
    Brain Pathol; 2019 Mar; 29(2):155-163. PubMed ID: 30051525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prion neurotoxicity.
    Le NTT; Wu B; Harris DA
    Brain Pathol; 2019 Mar; 29(2):263-277. PubMed ID: 30588688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenic mutations within the hydrophobic domain of the prion protein lead to the formation of protease-sensitive prion species with increased lethality.
    Coleman BM; Harrison CF; Guo B; Masters CL; Barnham KJ; Lawson VA; Hill AF
    J Virol; 2014 Mar; 88(5):2690-703. PubMed ID: 24352465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.